Pablo Tebas

279 papers receiving 15.5k citations

Pablo Tebas's Hit Papers

Long-term safety of lentiviral or gammaretroviral gene-modified T cell therapies 2025 · 53 citations
530+5+10Years since publication2505007501k

Peers

Pablo Tebas
Comparison fields: 5 of 143
  • Virology 3.4k
  • Emergency Medicine 4.1k
  • Infectious Diseases 4.7k
  • Hepatology 692
  • Epidemiology 1.1k
Replace Peré Domingo with:
Peré Domingo Spain
Jan Gerstoft Denmark
Jennifer Hoy Australia
Eric S. Daar United States
Ronald J. Bosch United States
Adriano Lazzarin Italy
Dominique Salmon France
Benigno A. Rodriguez United States
José Ramón Arribas Spain
Shinichi Oka Japan
Pablo Tebas relative to Peré Domingo Spain Peré Domingo's profile →
Citations per field
00.5×1.5×2.2×
Peré Domingo · 1×
Citations per year

Countries citing papers authored by Pablo Tebas

Since Specialization
Citations

This map shows the geographic impact of Pablo Tebas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pablo Tebas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pablo Tebas more than expected).

Fields of papers citing papers by Pablo Tebas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pablo Tebas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pablo Tebas. The network helps show where Pablo Tebas may publish in the future.

Co-authors

The 25 scholars most cited alongside Pablo Tebas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Pablo Tebas Line = papers co-authored together Pablo Tebas links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 284 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Gene Editing of CCR5 in Autologous CD4 T Cells of Persons Infected with HIV
Hit paper breakdown →
20141111
2 2000458
3
Bone Mineral Density and Fractures in Antiretroviral-Naive Persons Randomized to Receive Abacavir-Lamivudine or Tenofovir Disoproxil Fumarate-Emtricitabine Along With Efavirenz or Atazanavir-Ritonavir: AIDS Clinical Trials Group A5224s, a Substudy of ACTG A5202
Hit paper breakdown →
2011422
4
Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption
Hit paper breakdown →
2016395
5
Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1
Hit paper breakdown →
2015388
6 2010322
7
Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection (GS-US-380-1489): a double-blind, multicentre, phase 3, randomised controlled non-inferiority trial
Hit paper breakdown →
2017314
8 2008288
9 2014282
10 2012269
11 1998266
12 2003266
13
Research priorities for an HIV cure: International AIDS Society Global Scientific Strategy 2021
Hit paper breakdown →
2021263
14 2020228
15 2003184
16 2007183
17 2019177
18 2012172
19 2016167
20 2005166

About Pablo Tebas

Pablo Tebas is a scholar working on Virology, Emergency Medicine, Infectious Diseases, Epidemiology and Hepatology, having authored 284 papers that have together received 16.1k indexed citations. Recurring topics across this work include HIV Research and Treatment (76 papers), HIV-related health complications and treatments (71 papers), HIV/AIDS drug development and treatment (58 papers), COVID-19 Clinical Research Studies (19 papers), HIV/AIDS Research and Interventions (13 papers), SARS-CoV-2 and COVID-19 Research (13 papers), Hepatitis C virus research (8 papers) and Hepatitis B Virus Studies (5 papers). The work is most often cited by research in Virology (3.4k citations), Emergency Medicine (4.1k citations), Infectious Diseases (4.7k citations), Hepatology (692 citations) and Epidemiology (1.1k citations). Pablo Tebas has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include William G. Powderly, Kevin E. Yarasheski, Grace A. McComsey, Kristin E. Mondy, Sherry Claxton, Ian Frank, Roger G. Bedimo, Henning Drechsler, Woraphot Tantisiriwat and Edgar Turner Overton. Their work appears in journals such as AIDS, Clinical Infectious Diseases, JAIDS Journal of Acquired Immune Deficiency Syndromes, The Journal of Infectious Diseases and Open Forum Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact